Competition Policy and IP in Pharmaceuticals: Economic Aspects
Oxford, England
17 May 2011
Hosted By: The Oxford Centre for Competition Law and Policy
NERA Director Dr. Mark Williams, who leads the firm's European Competition Policy Practice, spoke about "Competition Policy and IP in Pharmaceuticals: Economic Aspects" at a conference on competition law and the pharmaceutical industry, hosted by the Oxford Centre for Competition Law and Policy on 17 May 2011. The presentation focused on various topical issues in pharmaceuticals antitrust, including parallel trade, pay for delay, and economic aspects of the IP-competition policy interface. The event featured leading academics, practitioners, and competition officials, including from the Federal Trade Commission, European Commission, and Office of Fair Trading.
To learn more, please visit the website of the Oxford Centre for Competition Law and Policy.
To contact us about this event, please click here.
